Metabolic bariatric surgery shows enduring weight reduction and improvement in obesity-related comorbidities. Both OAGB and SADJB-SG procedures lead to significant improvements in BMI, diabetes, hypertension, and dyslipidemia over three years. Patients also experience a substantial reduction in 10-year MACE, stroke, and atherosclerotic CVD risks. These findings highlight the effectiveness of OAGB and SADJB-SG in metabolic bariatric surgery.
Journal Article by Pan HM, Lee WJ (…) Hsu KF et 4 al. in Int J Surg
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.